1D'Amato RJ ,Loughnan MS,Flynn E ,et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci ,USA ,1994,91:4082-4085.
2Kumar S,Witzig TE,Rajkumar SV,et al. Thalidomide:current role in the treatment of non-plasma cell malignancies. Clin Oncol, 2004, 15 : 2477-2488.
3Panteli K,Zagorianakou, Bai M, et al. Angiogenesis in chronic myelopro liferative disease detected by CD34 expression. Eru J Haemotol,2004,72:410-415.
4Strupp C, Germing U,Scherer A, et al. Thalidomide for the treatment of idiopathic myelofibrosis. Eru J haematol, 2004,72.52-57.
5Mesa RA,Elliott MA,Schroeder G, et al. Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.Mayo Clin Proc ,2004,79 : 883-889.
